Actions

Flow Cytometry: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 39: Line 39:
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
|
|
'''[[TCRαβ|<span style="color:navy">'''TCRαβ'''</span>]]'''
'''[[TCRαβ|<span style="color:maroon">'''TCRαβ'''</span>]]'''
|}
|}
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
|
|
'''[[TCRγδ|<span style="color:navy">'''TCRγδ'''</span>]]'''
'''[[TCRγδ|<span style="color:maroon">'''TCRγδ'''</span>]]'''
|}
|}
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
|
|
'''[[HLA-DR|<span style="color:navy">'''HLA-DR'''</span>]]'''
'''[[HLA-DR|<span style="color:maroon">'''HLA-DR'''</span>]]'''
|}
|}
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px"
|
|
'''[[IgM|<span style="color:navy">'''IgM'''</span>]]'''
'''[[IgM|<span style="color:maroon">'''IgM'''</span>]]'''
|}
|}



Revision as of 22:56, 16 June 2023

  • Individual immunophenotypic markers used in diagnosis
  • Reactivity patterns used to distinguish disorders (reactivity patterns)
  • Immuonophenotype of specific conditions (disease specific patterns)


Markers used mainly for gating:

CD45



Non CD-classified markers frequently used in haematological diagnosis

kappa

lambda

FMC7

TDT

MPO

TCRαβ

TCRγδ

HLA-DR

IgM




CD-classified markers frequently used in leukaemia diagnosis

CD2

CD3

CD5

CD10

CD11c

CD13

CD14

CD19

CD22

CD23

CD25

CD33

CD34

CD38

CD79a

CD103

CD117

CD138

CD200




Other markers helpful in diagnosis


TCRαβ

TCRγδ

HLA-DR

IgM


CD1a

CD4

CD7

CD8

CD11b

CD15

CD16

CD20

CD24

CD41

CD43

CD56

CD57

CD61

CD64

CD65

CD123

CD235


test